New Triple-Threat attack on advanced liver cancer before surgery
Disease control
Recruiting now
This study is testing a three-part treatment given before surgery for a serious form of liver cancer that has grown into a major blood vessel. The goal is to see if combining targeted radiation, an immunotherapy drug (camrelizumab), and a drug that blocks tumor blood supply (apat…
Phase: PHASE2 • Sponsor: Yongyi Zeng • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC